Hormone Therapy 101: The History, the Myths, and What the Evidence Shows

Hormone therapy is 1 of the most effective tools we have for the Midlife years, and 1 of the most misunderstood. This chapter is a 101, so you understand your options and can ask good questions. The right plan for you is a decision to make with a skillful prescriber who knows the current evidence.

A word on names. You will hear HRT, hormone replacement therapy, and MHT, menopausal hormone therapy. They mean the same thing.

Hormone therapy can be genuinely supportive. It is also a personal choice, and it is 1 path among several. Some Women use it for decades, some for a few years, and some decide it is not for them at all. Each of those can be a wise decision when it is an informed one.

· · ·

Herbs, food, movement, Qigong, and hormone therapy can all sit in the same plan. I hear from Women who were told by 1 camp to never touch hormones, and by another that food and breath work are a waste of time. The body does not sort itself into camps. Yoga, Reiki, and breath work are beautiful and necessary, and on their own they cannot put estradiol back into your bloodstream. Hormone therapy, on its own, cannot heal an inflamed gut or refill an empty ferritin.

How the Boat Sank: The Women's Health Initiative

In 2002, part of a large study called the Women's Health Initiative, the WHI, was stopped early, and a press announcement told the world that hormone therapy raised the risk of breast cancer, heart attack, and stroke. The headlines were everywhere. Almost overnight, Women stopped their hormones and doctors stopped prescribing them. Hormone therapy use among postmenopausal Women in the United States fell from about 27 percent in 1999 to under 5 percent by 2020.

Here is what the headlines left out:

• The Women studied were not the Women who usually start hormones. Their average age was 63, often more than a decade past Menopause, and many already carried risk factors for heart disease.
• The hormones were not the ones most prescribers reach for today. The study used conjugated equine estrogens, made from pregnant horses' urine and taken as a pill, together with a synthetic progestin called medroxyprogesterone acetate. Today many Women use estradiol through the skin and micronized progesterone, both identical to the hormones your body makes.
• The breast cancer increase was small in absolute terms. In the combined arm, it came to fewer than 1 extra case per 1,000 Women per year.
• The estrogen-alone arm told a different story. In Women who had had a hysterectomy and took estrogen alone, breast cancer diagnoses and breast cancer deaths were lower over about 20 years of follow-up.

A generation of Women went without treatment that could have helped them. In November 2025, the FDA moved to remove most of the boxed warnings, as the next section explains.

Think about what that stretch of years meant in real lives. A Woman of 51 in 2003, soaked through every night and waking at 3 AM, was often told hormones were too dangerous and sent home with nothing, or with a sleep aid. Her hot flashes may have faded in time, and the bone she lost in those years did not come back on its own.

The same headlines shaped medical training. Many doctors who trained in the years after 2002 learned hormone therapy mainly as a list of risks. If your doctor hesitates, that hesitation often comes from that training and from caring about your safety. The research has moved a long way since, and a prescriber who has followed it can walk you through what changed.

In 2024, JAMA published a review of the WHI trials and what they mean for clinical practice, led by Dr. JoAnn Manson, a longtime WHI investigator. It brought more than 2 decades of follow-up together in 1 place.

For Women under 60, in the early years of Menopause, the review concluded that hormone therapy is appropriate to treat bothersome hot flashes and night sweats, and that these younger Women see a more favorable balance of benefit. It supports starting hormone therapy before 60 for Women with bothersome Menopause symptoms.

Research like this is often estimated to take about 17 years, on average, to move into guidelines, medical school, and the courses doctors take to stay current, as 'Why Your Doctor Isn't Having This Conversation With You' explains. If that usual lag holds, the 2024 review may not shape the typical exam room until around 2041.

The FDA's November 2025 action, in the next section, is 1 sign the official record is catching up. You do not have to wait for the rest of the system. Prescribers who follow this research are practicing now, and 'How to Ask Your Doctor for These Tests' shows you how to find them.

The 2025 FDA Action, in Context

A boxed warning is the strongest warning the FDA places on a prescription label, the black-bordered box at the top of the insert. The FDA added boxed warnings to estrogen products in 2003, in the wake of the WHI. For more than 20 years, a Woman of 48 opening her first box of patches read warnings about heart attack, stroke, breast cancer, and dementia drawn from a study of Women whose average age was 63.

In July 2025, the FDA convened an expert panel on hormone therapy for Menopause. In November 2025, the agency announced it would ask manufacturers to remove the boxed warnings about heart disease, breast cancer, and probable dementia. The boxed warning about uterine cancer stays on estrogen taken without progesterone, because that risk is real. It is the reason a Woman with a uterus takes progesterone alongside her estrogen.

Here is how to hold this news:

• A label change does not change your personal risk. Your age, your years since your last period, your history, the form, and the dose still decide your risk. The label now describes that risk more in line with current evidence.
• The risks are still listed. They move from the box into the body of the label, where your prescriber and pharmacist can weigh them with you.
• Labels change on a timeline. Manufacturers submit revised labels after an announcement like this, so the insert in your box may lag behind the news for a while.
• Experts do not all agree on every detail. Most menopause specialists welcomed the change. Some raised concerns about how quickly it happened and about keeping the real risks in view. Both kinds of voices want Women to have accurate information.

The Timing Hypothesis: Why When You Start Matters

After 2 decades of reanalysis, the same hormone appears to behave differently depending on when in your life you start it. Researchers call this the timing hypothesis, sometimes the window of opportunity.

When the WHI data were separated by age, the picture changed. Women who started hormones in their 50's, or within about 10 years of their final period, had a lower rate of coronary heart disease events and deaths than the average suggested, while the risks concentrated in Women who started in their 60's and 70's. The Women in the headlines and the Women who usually start hormones were living different stories.

1 leading explanation lives in your blood vessels. In a younger vessel with healthy lining, estrogen helps the vessel relax, supports healthy cholesterol handling, and appears to slow the build-up of plaque. In a vessel that already carries years of established plaque, starting estrogen, especially as a pill that raises clotting factors, may do more harm than good. Estrogen seems to protect healthy tissue better than it repairs damaged tissue.

A trial called ELITE tested this directly. Researchers gave oral estradiol or placebo to Women who were either less than 6 years past Menopause or 10 or more years past it, and measured the thickness of the carotid artery wall over about 5 years. In the early group, estradiol slowed the thickening of the artery wall. In the late group, it made no difference.

Another trial, KEEPS, gave Women in their late 40's and 50's, within 3 years of their final period, either an estrogen pill, an estradiol patch, or placebo for 4 years. Hormone therapy did not change artery wall thickening in that trial, and it improved hot flashes, sleep, and several measures of mood and quality of life without a signal of harm. Put together with ELITE, the message for younger Women is reassuring, and the size of the heart benefit is still being studied.

The brain story is encouraging. Lab work, brain imaging, a large insurance-records study, and a 2026 study of donated brains all point toward protection, and 'Protecting Your Brain for Life', in Part 3, gathers those findings. The alarming headlines of the early 2000s came from studies that used different hormones, oral conjugated estrogens, alone or with a synthetic progestin, in older Women, and in November 2025 the FDA moved to remove the boxed dementia warning.

Many Women start hormone therapy after 60, and it helps them tremendously. For a Woman who is 62, or 15 years past her last period, the decision is individual, made with a prescriber who knows the current evidence, and estradiol through the skin carries a lower clot risk than a pill. Vaginal estrogen is appropriate at any age, and a Woman who started in her early 50's and is doing well can often continue into her 60's and beyond.

What Hormone Therapy Can Do

• Hot flashes and night sweats: hormone therapy is the most effective treatment we have.
• Sleep: fewer night sweats, and oral progesterone at night helps many Women sleep.
• Vaginal dryness, painful sex, and urinary symptoms.
• Bone: it prevents bone loss, and in the WHI it reduced hip fractures.
• Mood in Perimenopause: for some Women, steadier hormones bring a steadier mood.
• Heart and metabolism: started before 60, or within 10 years of Menopause, estrogen is associated with lower rates of heart disease and type 2 diabetes.
• Joint aches and brain fog: many Women notice improvement, though the research here is younger.

On hot flashes, the numbers are strong. A Cochrane review of randomized trials found that estrogen reduced the weekly number of hot flashes by about 75 percent compared with placebo. For many Women, the first thing they notice is a full night of sleep.

Bone: What the Evidence Shows

Estrogen restrains the cells that break bone down. When estrogen falls, that restraint eases, and bone is taken apart faster than your body can rebuild it. In SWAN, bone loss sped up about a year before the final period and ran at roughly 2.5 percent a year at the spine until about 2 years after it. That loss is silent. There is no pain and no warning, until a bone breaks.

Hormone therapy is FDA-approved for preventing postmenopausal osteoporosis. In the WHI, Women taking combined hormones had about 34 percent fewer hip fractures than Women on placebo, and fewer fractures overall. This protection held in a group of Women who were not selected for low bone density.

2 details matter for your planning:

• The protection lasts while you take it. When hormone therapy stops, bone loss resumes, often at the pace of the early Menopause years. If you stop, ask your prescriber how your bones will be protected afterward, and ask for a DEXA scan to track it.
• Hormones work best alongside the basics. Strength training, enough protein, vitamin D, vitamin K2, and magnesium, which the Estrogen section of this guide covers, give hormone therapy a skeleton to protect.

If you already have osteoporosis, hormone therapy may be 1 of several options, alongside medications made specifically for bone. That is a conversation for your prescriber, ideally with a DEXA result in hand.

Heart: What the Evidence Shows

Heart disease is the leading cause of death in Women, and a Woman's risk rises after Menopause. LDL cholesterol typically climbs across the transition, fat shifts toward the belly, and blood vessels lose some of the flexibility estrogen supported.

What the evidence shows, in plain terms:

• Timing changes the result. A Cochrane review found that Women who started hormone therapy within 10 years of Menopause had about 30 percent lower death rates and roughly half the coronary heart disease of Women on placebo. The same review found a higher risk of blood clots.
• Started late, the picture reverses. In Women more than 10 years past Menopause, the reviews found no heart benefit and a higher risk of stroke and clots.
• The form matters. Estrogen through the skin skips the liver's first pass, so it does not raise clotting factors the way a pill does. Observational studies link skin-based estradiol to a lower clot and stroke risk than oral estrogen.
• Hormone therapy is not prescribed for the heart alone. The Menopause Society does not recommend starting hormone therapy only to prevent heart disease. For a Woman who starts for her symptoms, in the right window, the heart evidence is reassuring.

Your heart is protected by many hands at once: blood pressure, blood sugar, cholesterol, movement, sleep, not smoking, and lowering chronic inflammation. Hormone therapy can be 1 of those hands.

Breast Cancer: What the Evidence Shows

• Common belief: hormone therapy causes breast cancer. The evidence is more nuanced. In the WHI, estrogen alone lowered breast cancer diagnoses and deaths. Estrogen combined with that synthetic progestin was linked to a small increase, fewer than 1 extra case per 1,000 Women per year, which The Menopause Society describes as similar to or lower than the risk from alcohol or obesity. With estrogen plus a progestogen, the risk rises with longer use.
• Common belief: if you have ever had cancer, you can never use hormones. A history of cancer does not automatically rule hormone therapy out. It depends on the kind of cancer, whether it was hormone-sensitive, and your oncologist's input. Many cancers are not driven by hormones at all.
• A family history of breast cancer is not, by itself, a reason to avoid hormone therapy.
• After breast cancer, estrogen for your whole body is usually avoided, especially if your cancer was hormone-receptor positive, and research on it is mixed, so it is a case-by-case decision made with your oncologist. Low-dose vaginal estrogen is a different conversation. ACOG's 2021 guidance supports considering it for survivors whose symptoms do not respond to other treatment, together with their oncologist.

Keep your breast screening up to date before you start and while you are on hormone therapy. Your prescriber will usually want a current mammogram on file. Hormone therapy can make breast tissue look denser on a mammogram for some Women, so let the imaging center know you are on it.

Who Should Not Use It, or Should Use It Carefully

Estrogen for your whole body is usually avoided, or used only with specialist input, if you have a current or past hormone-sensitive cancer, a past blood clot or stroke, active liver disease, or unexplained vaginal bleeding. A clotting history or migraine with aura usually points toward skin-based estrogen rather than a pill.

The British Menopause Society states that migraine aura does not rule out hormone therapy, and it prefers estradiol through the skin, at the lowest dose that controls symptoms, for its steadier levels. 'Migraines and Headaches: Why They Change in Perimenopause, and What Helps' explains why steadiness protects the migraine brain.

Why Some Women Love It, and Why Some Do Not

• Why some love it: sleep comes back, hot flashes stop, the fog lifts, joints ache less, sex is comfortable again, and many say they feel like themselves again.
• Why some do not: breast tenderness or spotting at the start, headaches, a daily routine, cost when insurance does not cover a form, skin reactions to patches, fear left over from 2002, or simply preferring not to take a hormone. Side effects often settle within the first 3 months, or with a change in dose or form.